Brazilian Health Regulatory Agency (Anvisa)

The Brazilian Health Regulatory Agency (Anvisa) is an autarchy linked to the Ministry of Health, part of the Brazilian National Health System (SUS) as the coordinator of the Brazilian Health Regulatory System (SNVS), present throughout the national territory.

Anvisa’s role it to promote the protection of the population’s health by executing sanitary control of the production, marketing and use of products and services subject to health regulation, including related environments, processes, ingredients and technologies, as well as the control in ports, airports and borders.


New clinical trial for Covid-19 vaccine approved

The approval involves two vaccines based on ribonucleic acid (RNA), and will count on 29,000 volunteers, including 1,000 in Brazil, specifically in São Paulo and Bahia.

International report advises on liver injuries

Anvisa participated in the preparation of the report published by the Council for International Organizations of Medical Sciences.

Norm regulating import of ICU equipment is published

The measure is applicable to several items, such as ventilators, vital signs monitors, and infusion pumps.